The inhibition of URAT1 in WAT by dotinurad induces the browning of WAT, and the inhibition of URAT1 in BAT increases the expression of UCP-1 and decreases the production of ROS, which may reduce body weight and visceral fat and may improve insulin resistance as well as glucose and lipid metabolism. This evidence concerns the gene UCP1 and Insulin resistance.